Mutations in the SPTLC1 gene are a cause of juvenile amyotrophic lateral sclerosis that may be amenable to serine supplementation
Janel O. Johnson, Ruth Chia, Danny E. Miller, Rong Li, Yevgeniya A. Abramzon, Ravindran Kumaran, Nada F. Alahmady, Faraz Faghri, Alan Edward Renton, Simon D. Topp, Hannah A. Pliner, Jesse Raphael Gibbs, Jinhui Ding, N. Smith, Natalie Landeck, , Bryan J. Traynor
The paper identifies de-novo SPTLC1 mutations in juvenile ALS patients and suggests serine supplementation may alleviate symptoms.
bioRxiv · Jun 29, 2020 · PreprintGenetics